Trulieve Cannabis Corp - TCNNF STOCK NEWS

Trulieve Cannabis Corp. announced a record revenue of $938.4 million for 2021, representing an 80% increase year-over-year. The quarterly revenue for Q4 2021 reached $305.3 million, up 36% sequentially. Despite the strong revenue growth, the company experienced a decline in gross margin to 60.3% from 74.1% in 2020, primarily due to diversification into lower-margin markets. Net income for 2021 was $18.0 million, with an adjusted EBITDA of $384.6 million. Trulieve anticipates revenue between $1.3 billion to $1.4 billion for 2022.

Trulieve Cannabis Corp. has opened a new medical cannabis dispensary in Boca Raton, Florida, as of March 16, 2022. The dispensary aims to enhance patient access to medical cannabis, featuring a 25% discount for registered patients during the grand opening. The location provides a wide array of THC and CBD products, and offers services like home delivery and online ordering. Trulieve continues to expand its market presence across Florida, Arizona, and Pennsylvania, focusing on enriching patient care and community engagement.

Trulieve Cannabis Corp. has announced an exclusive partnership with Ethan Zohn, winner of Survivor: Africa and a two-time cancer survivor, to serve as the brand ambassador for Momenta, Trulieve's wellness cannabis brand. Zohn will engage in educational outreach and share his cannabis wellness journey. The partnership aims to enhance cannabis awareness and education across the U.S. Momenta is currently available in Florida, Massachusetts, and West Virginia, offering a range of easy-to-dose products designed to promote overall well-being.

Trulieve Cannabis Corp. will hold a conference call on March 30, 2022 at 8:30 AM Eastern Time to discuss its fourth quarter and full year 2021 financial results. The call will feature CEO Kim Rivers, CFO Alex D'Amico, and President Steve White, highlighting the company's recent acquisition of Harvest Health & Recreation. Interested parties can join via phone or through a live audio webcast, with details available in the press release. Trulieve operates across 11 states, focusing on expanding its market presence and customer access.

Trulieve Cannabis Corp. (OTCQX: TCNNF) announced its participation in two upcoming conferences in March 2022. President Steve White will attend the 34th Annual Roth Conference on March 14, while CMO Valda Coryat will join a panel discussion at the 2022 SXSW Conference on March 15, focusing on cannabis in consumer packaged goods. As a leading multi-state operator in the U.S., Trulieve operates in 11 states, with significant market presence in Arizona, Florida, and Pennsylvania, positioning itself for growth and expansion.

Trulieve Cannabis Corp. has announced an exclusive partnership with Wiz Khalifa's Khalifa Kush brand, set to launch in Florida this summer. Trulieve will be the exclusive producer, processor, and retailer of Khalifa Kush products in Florida and other northeastern markets. Trulieve is renowned for its extensive range of premium cannabis products, serving the largest medical cannabis market in the U.S. The collaboration aims to enhance customer experiences and expand the brand's footprint across multiple states.

Trulieve Cannabis Corp. is hosting a Listening and Education Tour in Georgia to engage local leaders on the benefits of the cannabis industry. The inaugural event will occur on February 25, 2022, at the Carolyn Harris Performing Arts Center in Adel. Moderated by Champ Bailey, the tour aims to discuss medical, economic, agricultural, and expungement opportunities. Trulieve received a Class 1 production license from the Georgia Access to Medical Cannabis Commission in July 2021. Community participation is encouraged, and future dates will be announced.

Trulieve Cannabis Corp. has finalized the acquisition of a 64,000 sq. ft. cultivation facility in Phoenix, Arizona for $13.75 million. This facility enhances the company’s cultivation capacity and strengthens its market presence in the Southwest. It also serves Trulieve’s 17 dispensaries in Arizona, providing high-quality products to both medical and adult-use customers. CEO Kim Rivers emphasized the strategic importance of this acquisition for improving supply chain capacity and expanding service to a larger customer base.